ARTICLE
20 October 2022

Holland & Knight Health Dose: October 18, 2022

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences
Holland & Knight are most popular:
  • within Strategy topic(s)

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • Congress This Week
  • COVID-19 Public Health Emergency Extended through Mid-January
  • New Executive Order Directs HHS to Leverage CMS Innovation Center to Improve Access to and Lower Drug Costs
  • IRA Implementation Update
  • Medicare 340B Payment Cut Ending for 2022
  • Forthcoming Rules
  • FDA Debates Removing Preterm Birth Preventive Drug From Market, Reigniting Criticisms of Accelerated Approval Pathway
  • FDA Seeks Public Feedback on Distributed and Point-of-Care Drug Manufacturing
  • Treasury Department Finalized Family Glitch Rule
  • Medicare Open Enrollment Oct. 15 through Dec. 7
  • FDA, CDC Green Light Omicron-Targeted Booster for Young Children; Vaccine Rates Remain Stagnant
  • CMS Extends, Updates BPCI Advanced Model

Read the full Health Dose

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More